Fermenta Biotech adds plant-based Vitamin D3 capacity at Dahej
Fermenta Biotech is investing ₹110 crore to expand plant-based Vitamin D3 and derivatives production in Dahej, targeting supplement, nutraceutical, fortified-food and beverage brands seeking vegetarian, clean-label inputs. Commercial production is expected in FY28.
What happened
Fermenta Biotech is investing ₹110 crore to expand plant-based Vitamin D3 and derivative production at Dahej, targeting Indian supplement, nutraceutical,
Key facts
- ₹110 crore expansion programme
- ₹60 crore for plant-based Vitamin D3 and derivatives capacity
- Around 1 tonne annual plant-based Vitamin D3 capacity
- 50 kg annual Vitamin D3 derivatives capacity
- 75 kilolitres fermentation capacity
- 53% of FY26 consolidated revenue from human nutrition
- ₹551 crore FY26 consolidated revenue
- ₹1,000-1,500 crore India plain Vitamin D3 60KIU market
- ₹20,600 crore broader vitamins and minerals segment
Why this matters
Brands and ingredient partners seeking plant-based Vitamin D3 should view Fermenta’s Dahej build-out as an opportunity for early supply agreements, co-development and long-term sourcing partnerships.
What to watch
- FY28 commissioning progress, regulatory clearances and customer-qualification milestones at Dahej.
- Announced supply agreements or product launches by leading Indian supplement, gummies, fortified dairy-alternative and beverage brands.
- Plant-based Vitamin D3 pricing versus conventional lanolin-derived Vitamin D3 and imported alternatives.
- FSSAI rule changes or enforcement that increase vitamin-fortification adoption and claim scrutiny.
- Competitive capacity additions from global fermentation, algae-derived or other non-animal Vitamin D suppliers.
- Evidence of retailer assortment growth in vegan, vegetarian and clean-label bone-health, immunity and women's-health products.
- Secure multi-year offtake agreements with Indian supplement, gummy and fortified-food manufacturers before commissioning.
- Build application-development support for beverage, dairy-alternative and bakery fortification, where stability and dosage validation can slow adoption.
- Pursue export customer approvals in North America, Europe and Asia-Pacific markets with established vegan and clean-label supplement demand.
- Develop derivative formats and premixes that reduce formulation complexity for consumer-brand customers.
- Expect nutraceutical and functional-food brands to test vegetarian Vitamin D3 launches and reformulations ahead of FY28 supply availability.